Cochlear, AU000000COH5

Cochlear stock: Company maintains FY27 outlook after CMD

Published on 11/17/2026 at 20:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cochlear stock keeps its FY27 outlook after Capital Markets Day. Management still sees low-single-digit sales growth and underlying profit of AUD 330 million to AUD 350 million.

Cochlear outlook and leadership

  • Cochlear maintained its FY27 sales and profit outlook after its Capital Markets Day.
  • The company expects growth across cochlear implants, upgrades and acoustics.
  • Cochlear also announced the departure of its North America president.
Cochlear, AU000000COH5, Illustration mit AI erstellt.

Cochlear Limited reaffirmed its FY27 outlook in an ASX announcement dated Friday, November 13, following its Capital Markets Day. The company expects low-single-digit sales growth in constant currency and underlying net profit of AUD 330 million to AUD 350 million, according to the Cochlear filing carried by 6ix.

Guidance and leadership update

Cochlear said trading from July through October remained in line with expectations. Developed-market cochlear implant volumes were a key growth driver, while the company outlined plans to expand patient access and strengthen referral pathways.

The announcement also covered the departure of Cochlear's North America president. The leadership change comes as the hearing-implant maker seeks further growth in developed markets and operational improvements.

Evening market context

Cochlear stock traded at 92.42 euros on Lang & Schwarz at 8:38 p.m. CET on Tuesday, November 17, 2026.

Cochlear Limited

  • Company: Cochlear Limited
  • ISIN: AU000000COH5
  • Ticker: COH
  • Home exchange: Australian Securities Exchange
  • Lang & Schwarz quote: 92.42 euros on November 17, 2026, at 8:38 p.m. CET

The broader Australian market is represented by the S&P/ASX 200.

More news and analyses on Cochlear stock

Disclaimer...
en | AU000000COH5 | COCHLEAR | boerse | 70528542 | bgmi